EMIRODATAMAB

UNII:	P9I9Z3MF7Z
Formula:
Preferred Substance Name:	EMIRODATAMAB

2449199-61-3
AMG 427
AMG-427
ANTI-FLT3/CD3 BITE ANTIBODY AMG 427
EMIRODATAMAB [INN]
EMIRODATAMAB [USAN]
EMIRODATAMAB [WHO-DD]
EXTENDED HALF-LIFE ANTI-FLT3 X ANTI-CD3 BITE (BISPECIFIC T CELL ENGAGER) ANTIBODY CONSTRUCT
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN FMS-LIKE TYROSINE KINASE FLT3) (HUMAN MONOCLONAL FLT3_BISPECIFIC_1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN MONOCLONAL FLT3_BISPECIFIC_1 SINGLE-CHAIN VARIABLE FRAGMENT VH2-(GGGGS)3-VL2) FUSION PROTEIN WITH PEPTIDE LINKER (GGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)6 FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

EMIRODATAMAB

Synonyms and Mappings

Resources